Alec Machiels, Director at Apellis Pharmaceuticals, Inc. (APLS), sold 1,250 shares at $40.56 ($51K) on 2022-01-14, disclosed to the SEC on 2022-01-19.
Open-market sale of $51k APLS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| APLS | SELL | 2023-09-19 | $56K | — | Filing → |
| APLS | SELL | 2023-09-18 | $113K | — | Filing → |
| APLS | SELL | 2023-07-18 | $162K | — | Filing → |